Literature DB >> 5910530

[Contribution to the knowledge of the mode of action and toxicology of epsilon-aminocaproic acid].

D Rezakovic, A Nikulin, P Stern.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5910530     DOI： 10.1007/bf01632399

Source DB:  PubMed          Journal:  Blut        ISSN： 0006-5242


× No keyword cloud information.
  7 in total

1.  [TRIAL TREATMENT BY EPSILON-AMINOCAPROIC ACID OF PATIENTS WITH HEMORRHAGIC SYNDROMES, ESPECIALLY SYNDROMES RELATED TO A THROMBOCYTOPENIA].

Authors:  A CATTAN; L SCHWARZENBERG; M SCHNEIDER; J L AMIEL; G MATHE
Journal:  Presse Med       Date:  1963-10-19       Impact factor: 1.228

2.  Fibrinolysis and fibrinolytic activity in man.

Authors:  S SHERRY; A P FLETCHER; N ALKJAERSIG
Journal:  Physiol Rev       Date:  1959-04       Impact factor: 37.312

3.  [Prevention and treatment by epsilon-aminocaproic acid of fibrinolytic syndromes in surgery].

Authors:  L LEGER; M LANDE; R FOURNET
Journal:  Presse Med       Date:  1963-04-20       Impact factor: 1.228

4.  Antifibrinolytic activity and metabolism of 6-aminocaproic acid in man.

Authors:  I M NILSSON; A SJOERDSMA; J WALDENSTROM
Journal:  Lancet       Date:  1960-06-18       Impact factor: 79.321

5.  The thromboplastin generation test.

Authors:  R BIGGS; A S DOUGLAS
Journal:  J Clin Pathol       Date:  1953-02       Impact factor: 3.411

6.  The effect of intravenous injection of trypsin inhibitor on the coagulation of blood.

Authors:  H J TAGNON; J P SOULIER
Journal:  Blood       Date:  1948-10       Impact factor: 22.113

7.  EFFECTS OF EPSILON AMINO CAPROIC ACID (EACA) ON SURVIVAL OF FIBRINOGEN I-131 AND ON FIBRINOLYTIC AND COAGULATION FACTORS IN DOGS.

Authors:  J H LEWIS
Journal:  Proc Soc Exp Biol Med       Date:  1963-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.